ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $259 | -49.5% | 78,143 | -40.9% | 0.10% | -47.4% |
Q4 2022 | $513 | -99.9% | 132,301 | -13.1% | 0.19% | +24.4% |
Q3 2022 | $370,000 | +22.5% | 152,301 | 0.0% | 0.16% | +22.8% |
Q2 2022 | $302,000 | +8.2% | 152,301 | 0.0% | 0.13% | +42.7% |
Q1 2022 | $279,000 | +29.8% | 152,301 | 0.0% | 0.09% | +21.9% |
Q4 2021 | $215,000 | – | 152,301 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |